Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie
2026-02-26 07:30:11 ET
MRK and ABBV stocks’ FQ4 earnings
I last covered AbbVie Inc. ( ABBV )( ABBV:CA ) on Jan 8, 2026, with an article titled “AbbVie: The Dividend Does Not Lie”. The article was triggered by ABBV’s dividend declaration made for Q1 2026 and rated the stock as a hold. As for Merck & Co., Inc. ( MRK ), my last analysis dated further back to July 16, 2025. That article was triggered by the Executive Order that President Trump announced to lower drug prices for American consumers at that time. It also rated MRK as a hold....
Read the full article on Seeking Alpha
For further details see:
Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVieNASDAQ: ABBV
ABBV Trading
-0.67% G/L:
$226.69 Last:
2,370,266 Volume:
$225.12 Open:



